Clinical Trials Directory

Trials / Unknown

UnknownNCT00595348

Korean Hereditary Breast Cancer Study

Status
Unknown
Phase
Study type
Observational
Enrollment
2,250 (estimated)
Sponsor
Korean Breast Cancer Study Group · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Accepted

Summary

1. To evaluate the prevalence of BRCA1/2 mutation of breast cancer patients with family history of breast/ovarian cancer. 2. To evaluate the prevalence of BRCA1/2 mutation of breast cancer patients without family history, but high risk of hereditary cancer. 3. To evaluate the prevalence of BRCA1/2 mutation of family member of BRCA1/2 mutation. 4. To evaluate the prevalence of ovarian cancer of population of above 3 groups.

Detailed description

1. To find founder mutation in Korean 2. To correlation prevalence with risk evaluation 3. To find risk factors concerning life style

Conditions

Timeline

Start date
2007-11-01
Primary completion
2012-05-01
Completion
2017-05-01
First posted
2008-01-16
Last updated
2011-05-11

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT00595348. Inclusion in this directory is not an endorsement.